Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myxedema coma.

Maxwell P Kwaku1, Kenneth D Burman

  • 1Endocrine Section, Washington Hospital Center, Washington, DC 20010-2975, USA.

Journal of Intensive Care Medicine
|August 23, 2007
PubMed
Summary
This summary is machine-generated.

Myxedema coma, a severe form of hypothyroidism, is rare but challenging to manage. Optimal thyroid hormone replacement therapy, using thyroxine alone or with triiodothyronine, is effective with intensive care support.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical and clinical performance of the updated Elecsys Anti-TPO II assay for the detection of antibodies against thyroid peroxidase to aid in the diagnosis of autoimmune thyroid diseases.

Clinical chemistry and laboratory medicine·2026
Same author

Differentiated Thyroid Cancer Is Associated With Sex-specific Immune Response.

Journal of the Endocrine Society·2025
Same author

Update in Papillary Thyroid Cancer.

Endocrinology and metabolism clinics of North America·2025
Same author

Thyroid Cancer: An Update in Causal Mechanisms, Diagnosis, Initial Treatment, and Long-Term Management.

Endocrinology and metabolism clinics of North America·2025
Same author

Association of Free Thyroxine With Progression-Free Survival in Intermediate and High-Risk Differentiated Thyroid Cancer.

The Journal of clinical endocrinology and metabolism·2024
Same author

A Rare Case of Persistent Multifocal Cribriform-Morular Thyroid Carcinoma.

AACE clinical case reports·2024
Same journal

Remimazolam Versus Midazolam for Sedation in Mechanically Ventilated Patients with Severe Pneumonia: A Randomized Controlled Trial.

Journal of intensive care medicine·2026
Same journal

Chronic Opioid use in Adult Survivors of Pediatric ICU Admissions in Nova Scotia: A Retrospective Cohort Study.

Journal of intensive care medicine·2026
Same journal

The Middle Ground: Midline Catheter use and Trainee Involvement in US Critical Care Fellowships.

Journal of intensive care medicine·2026
Same journal

Effect of Acetylsalicylic Acid on Mortality in Sepsis: A Systematic Review and Meta-Analysis.

Journal of intensive care medicine·2026
Same journal

Arterial Blood Gas-Derived Risk Models for 28-Day Mortality in Critically Ill Adults: A Retrospective Cohort Study.

Journal of intensive care medicine·2026
Same journal

Ethical Considerations and End-of-Life Care in Donor and Transplant Critical Care.

Journal of intensive care medicine·2026
See all related articles

Area of Science:

  • Endocrinology
  • Critical Care Medicine

Background:

  • Untreated hypothyroidism can lead to myxedema coma, a rare but severe condition.
  • Few cases are reported, possibly due to underreporting or better diagnosis of hypothyroidism.
  • Myxedema coma diagnosis and treatment remain challenging despite sensitive assays.

Purpose of the Study:

  • To review the current understanding and management of myxedema coma.
  • To discuss controversies regarding optimal thyroid hormone replacement therapy.

Main Methods:

  • Literature review of reported myxedema coma cases.
  • Analysis of evidence on thyroid hormone preparations for treatment.

Main Results:

  • Thyroid hormone replacement is effective when combined with ventilatory and hemodynamic support.

Related Experiment Videos

  • Optimal choice of thyroid hormone preparation (thyroxine and triiodothyronine) is debated.
  • Evidence suggests either thyroxine alone or combined with triiodothyronine can be effective.

    • Conclusions:

    • Myxedema coma management requires intensive care support.
    • Effective treatment strategies involve careful selection of thyroid hormone preparations.